ONPH 股价走势图
ONPH 财报
Oncology Pharma Inc
$0.07
-20.91%
$-0.01
收盘价：Apr 27, 16:00:00 GMT-4
$0.07
0%
$0
盘前：Apr 28, 09:05:48 GMT-4
返回
Oncology Pharma Inc (ONPH) 财报
关键数据
前收盘价
$0.0899
开盘价
$0.1
当日区间
$0.0711 - $0.1
52周范围
$0.0001 - $0.364
交易量
27.8K
平均成交量
34.1K
股息收益率
--
每股收益（TTM）
--
市值
$5.9M
什么是 ONPH？
Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company is headquartered in San Francisco, California. The firm is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company’s research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The firm offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company’s NanoSmart platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. Its anti-cancer drugs in combination with medications, for treating a variety of cancers, such as breast, ovarian, lung, bladder, Kaposi's sarcoma, lymphoma and acute lymphocytic leukemia is doxorubicin. Its portfolio also includes Connect2Med, Sybleu, Inc. and Regen.
